Disruption of tumor N-glycosylation improves the efficacy of CAR T-cell therapy in solid carcinomas Feb. 7, 2022 No Comments
LISCure and Scripps collaborate on bacteria-mediated immuno-oncology candidates for cancer Feb. 4, 2022 No Comments
Co-stimulation with CD81 promotes CAR T-cell transduction toward naive T cells Feb. 4, 2022 No Comments
NBTXR3 improves survival in preclinical model of anti-PD-1-resistant lung cancer Jan. 28, 2022 No Comments
Novel nonviral engineered BAFF-CAR T cells show efficacy in multiple B-cell cancer models Jan. 28, 2022 No Comments
IL-2Rbeta agonist MDNA-11 shows promising results in preclinical cancer models Jan. 27, 2022 No Comments
INmune Bio collaborates with CUHK to evaluate INKmune in nasopharyngeal cancer Jan. 26, 2022 No Comments
HCW-9218 potentiates antitumor efficacy by reducing TIS-driven proinflammatory phenotype Jan. 26, 2022 No Comments
Pro-IL-12 could treat tumors with reduced toxicity compared to recombinant IL-12 Jan. 26, 2022 No Comments